Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Cheelcare Inc. (CHER.V) is a Canada-based healthcare services company operating within the healthcare staffing, clinical services, and medical clinic management industries. The company’s core focus is providing staffing solutions and healthcare services to public and private healthcare providers, including hospitals, long-term care facilities, and community-based clinics. Its revenue is primarily driven by contracted healthcare personnel services and the operation of owned or affiliated clinics.
Cheelcare positions itself as a vertically integrated healthcare services provider, combining staffing, clinical delivery, and infrastructure support to address workforce shortages and access-to-care challenges in Canada. Public disclosures indicate the company has evolved from a staffing-centric model toward a broader healthcare services platform, expanding its scope to include direct patient care delivery through clinics. Data inconclusive based on available public sources regarding the precise timeline of its corporate evolution and early-stage operations.
Business Operations
Cheelcare’s operations are organized around healthcare workforce solutions and clinical service delivery. The company generates revenue by supplying licensed healthcare professionals—such as nurses and allied health workers—to healthcare institutions on a contract basis, as well as through fees and billings associated with clinic-based patient services. Operations are primarily domestic, with activities concentrated in Canada.
The company controls operational assets related to workforce placement, clinical staffing management, and clinic administration. Publicly available information references subsidiaries and operating entities used to manage staffing and clinic operations; however, specific segmentation disclosures are limited. Data inconclusive based on available public sources regarding the full list of subsidiaries, proprietary technologies, or long-term exclusive service agreements.
Strategic Position & Investments
Cheelcare’s stated strategic direction emphasizes growth through healthcare service integration, expansion of clinic-based care, and scaling of staffing services to meet persistent healthcare labor shortages. The company has publicly discussed pursuing selective acquisitions and investments that enhance service breadth and geographic reach, particularly in outpatient and community healthcare settings.
Notable acquisitions and investment details have been disclosed in regulatory filings; however, publicly available summaries vary in specificity. Data inconclusive based on available public sources regarding the long-term financial performance of acquired entities and the materiality of individual investments to consolidated results.
Geographic Footprint
Cheelcare’s operational footprint is primarily within Canada, where it serves healthcare institutions and patients across multiple provinces. The company’s headquarters is located in Canada, and its market presence is focused on provincial healthcare systems and regional clinic networks.
There is no verified evidence of material operating revenues outside Canada as of the most recent public disclosures. International expansion has been referenced as a potential opportunity, but current operational influence remains domestic. Data inconclusive based on available public sources regarding any active international subsidiaries or joint ventures.
Leadership & Governance
Cheelcare is led by an executive team with experience in healthcare operations, staffing, and public company governance. Leadership emphasizes operational execution, healthcare access, and disciplined growth aligned with public healthcare system needs.
Key executives disclosed in public filings include:
- Mark McAllister – Chief Executive Officer
- Daniel Kenning – Chief Financial Officer
- Additional senior operational and clinical leadership roles – Titles and names vary by disclosure period
Data inconclusive based on available public sources regarding founder attribution and the full composition of the senior management team at all reporting dates.